News
EMERYVILLE, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT), a clinical-stage gene therapy company harnessing the power of directed evolution for targeted gene ...
Laser ultrasonic detection experiments were conducted for surface defects of different depths, and multiple sets of ultrasonic signal waveform were collected, and several feature vectors such as ...
--4 D Molecular Therapeutics, a clinical-stage gene therapy company harnessing the power of directed evolution for targeted gene therapies, announced a new collaboration with investigators at the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results